Innate Immune Mechanisms Contributing to Cancer Growth in Obesity
肥胖导致癌症生长的先天免疫机制
基本信息
- 批准号:10278250
- 负责人:
- 金额:$ 52.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AcidityAcidsAdultAffectAutomobile DrivingBiological AssayBlocking AntibodiesBlood donorCTLA4 geneCancer EtiologyCell physiologyCellsColon CarcinomaColorectal CancerCyclic AMPCyclic AMP-Dependent Protein KinasesDataDevelopmentDietDiseaseExhibitsFlow CytometryFrequenciesGenus HippocampusGrowthHigh Fat DietHumanImmuneImmune responseImpairmentInflammatory ResponseKRASG12DLipidsMC38Malignant NeoplasmsMediator of activation proteinModelingMusNon obeseObese MiceObesityOleic AcidsOutcomeOverweightPatientsPlayPopulationPredispositionPrimary carcinoma of the liver cellsProductionPrognosisRiskRoleSamplingSignal TransductionSocietiesSolid NeoplasmTNF geneTestingTherapeutic EffectTriglyceridesTumor ImmunityTumor-associated macrophagesUnited Statesanti-PD-1/PD-L1basecancer therapycell typecolon cancer patientscolon growthcytokinediet-induced obesitydietaryfatty acid oxidationhuman dataimmune checkpoint blockadeinnate immune mechanismsmacrophagemelanomamortalitymouse modelneoplasm immunotherapyneoplastic cellnovelobese patientsobesogenicoverexpressionrapid growthreceptorresponsesubcutaneoustherapy outcometumortumor growthtumor metabolismtumor microenvironment
项目摘要
Project Summary/Abstract
Colorectal cancer (CRC) is the second leading cause of cancer mortality in the United States, and obesity, which
affects 40% of the population, not only increases the risk of developing CRC, but also increases CRC mortality
through unknown mechanisms. Our preliminary studies demonstrate that CRC grows faster in mice rendered
obese through a high fat diet (HFD), and that the tumor associated macrophages (TAMs) in these mice exhibit
higher expression of the acid sensing receptor, GPR65, which is known to dampen the immune response.
Moreover, in HFD-induced obese mice lacking GRP65, TAMs secrete more TNF-α and tumor growth is retarded.
Given that TAMs but not normal tissue macrophages of obese mice exhibit increased GPR65, we examined the
pH of the tumors in these mice and found them to be more acidic. On the basis of these findings, we hypothesize
that excess lipids in the HFD alter tumor cell metabolism resulting in increased acid production, which potentiates
GPR65 expression and signaling in TAMs, causing them to become immunosuppressive and promote tumor
growth. To test this hypothesis we will pursue the following specific aims: 1) Determine the contribution of
GPR65 signaling to TAM function and CRC growth under conditions of obesity by determining if the cAMP-
PKA signaling axis, which functions downstream of GPR65, is activated in TAMs of obese mice and controls
TNF-α production. We will also analyze GPR65 expression and the cytokine secretion capacity of macrophages
from healthy blood donors and TAMs in CRC samples from non-obese and obese patients; 2) Identify the
mechanism by which HFD promotes GPR65 signaling in CRC TAMs by testing the ability of HFD and oleic
acid, a dietary triglyceride that is highly enriched in HFD tumors, to alter the oxidative potential, fatty acid
oxidation capacity and acid production of human tumor cells via flow cytometry, CyTOF and Seahorse assays.
We will also determine if a high-oleic-acid diet is sufficient to modify GPR65 expression and cytokine production
by TAMs, and examine if tumor acidity is required for the blunted inflammatory response of TAMs; and verify the
role of GPR65 in human macrophages and 3) Assess the effects of targeting GPR65 for tumor
immunotherapy in obese and nonobese mice with CRC and other tumor types, namely hepatocellular
carcinoma and melanoma, and assess the effects of checkpoint blocking antibodies on tumor growth and anti-
tumor immunity in GPR65+ and GPR-/- mice bearing these tumors. The results of these studies are expected to
not only reveal a critical mechanism responsible for accelerated tumor growth in the setting of obesity, but also
identify a novel target for the treatment of these cancers.
项目总结/摘要
结直肠癌(CRC)是美国癌症死亡率的第二大原因,而肥胖,
影响40%的人口,不仅增加了患CRC的风险,而且增加了CRC的死亡率
通过未知的机制。我们的初步研究表明,CRC在小鼠中生长得更快,
通过高脂饮食(HFD)肥胖,并且这些小鼠中的肿瘤相关巨噬细胞(TAM)表现出
酸敏感受体GPR 65的更高表达,已知其抑制免疫应答。
此外,在缺乏GRP 65的HFD诱导的肥胖小鼠中,TAM分泌更多的TNF-α,肿瘤生长受阻。
考虑到TAMs而非肥胖小鼠正常组织巨噬细胞表现出增加的GPR 65,我们检查了TAMs中的GPR 65。
这些小鼠肿瘤的pH值,发现它们更酸性。基于这些发现,我们假设
HFD中过量的脂质改变了肿瘤细胞的代谢,导致酸的产生增加,
TAMs中的GPR 65表达和信号传导,导致它们成为免疫抑制剂并促进肿瘤
增长为了检验这一假设,我们将追求以下具体目标:1)确定
GPR 65信号传导对TAM功能和肥胖条件下CRC生长的影响,通过确定cAMP-
在肥胖小鼠和对照组的TAM中,GPR 65下游起作用的PKA信号传导轴被激活
TNF-α产生。我们还将分析巨噬细胞的GPR 65表达和细胞因子分泌能力,
和来自非肥胖和肥胖患者的CRC样品中的TAM; 2)鉴定
HFD促进CRC TAM中GPR 65信号传导的机制,通过测试HFD和油酸
脂肪酸,一种在HFD肿瘤中高度富集的膳食甘油三酯,以改变氧化电位,
通过流式细胞术、CyTOF和Seahorse测定人类肿瘤细胞的氧化能力和产酸能力。
我们还将确定高油酸饮食是否足以改变GPR 65表达和细胞因子产生
通过TAM,并检查肿瘤酸度是否需要TAM的钝化炎症反应;并验证
GPR 65在人巨噬细胞中的作用和3)评估靶向GPR 65对肿瘤的作用
在患有CRC和其他肿瘤类型(即肝细胞癌)的肥胖和非肥胖小鼠中的免疫治疗
癌和黑色素瘤,并评估检查点阻断抗体对肿瘤生长和抗-
携带这些肿瘤的GPR 65+和GPR-/-小鼠的肿瘤免疫。这些研究的结果预计将
不仅揭示了肥胖症患者肿瘤生长加速的关键机制,
为这些癌症的治疗找到新的靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDGAR G. ENGLEMAN其他文献
EDGAR G. ENGLEMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDGAR G. ENGLEMAN', 18)}}的其他基金
Systems Biology of Tumor-Immune-Stromal Interactions in Metastatic Progression
转移进展中肿瘤-免疫-基质相互作用的系统生物学
- 批准号:
10729464 - 财政年份:2023
- 资助金额:
$ 52.61万 - 项目类别:
Targeting Lymph Node Dependent Immune Tolerance in Cancer
针对癌症中的淋巴结依赖性免疫耐受
- 批准号:
10210557 - 财政年份:2021
- 资助金额:
$ 52.61万 - 项目类别:
Project 3: Impact of tumor genetics on PDAC immunobiology and responses to macrophage-targeted immunotherapy
项目 3:肿瘤遗传学对 PDAC 免疫生物学的影响以及对巨噬细胞靶向免疫治疗的反应
- 批准号:
10704089 - 财政年份:2021
- 资助金额:
$ 52.61万 - 项目类别:
Innate Immune Mechanisms Contributing to Cancer Growth in Obesity
肥胖导致癌症生长的先天免疫机制
- 批准号:
10654802 - 财政年份:2021
- 资助金额:
$ 52.61万 - 项目类别:
Innate Immune Mechanisms Contributing to Cancer Growth in Obesity
肥胖导致癌症生长的先天免疫机制
- 批准号:
10430268 - 财政年份:2021
- 资助金额:
$ 52.61万 - 项目类别:
Project 3: Impact of tumor genetics on PDAC immunobiology and responses to macrophage-targeted immunotherapy
项目 3:肿瘤遗传学对 PDAC 免疫生物学的影响以及巨噬细胞靶向免疫治疗的反应
- 批准号:
10456771 - 财政年份:2021
- 资助金额:
$ 52.61万 - 项目类别:
Innate Immune Mechanisms Contributing to Cancer Growth in Obesity
肥胖导致癌症生长的先天免疫机制
- 批准号:
10706825 - 财政年份:2021
- 资助金额:
$ 52.61万 - 项目类别:
Project 3: Impact of tumor genetics on PDAC immunobiology and responses to macrophage-targeted immunotherapy
项目 3:肿瘤遗传学对 PDAC 免疫生物学的影响以及对巨噬细胞靶向免疫治疗的反应
- 批准号:
10187127 - 财政年份:2021
- 资助金额:
$ 52.61万 - 项目类别:
Targeting Lymph Node Dependent Immune Tolerance in Cancer
针对癌症中的淋巴结依赖性免疫耐受
- 批准号:
10366092 - 财政年份:2021
- 资助金额:
$ 52.61万 - 项目类别:
相似国自然基金
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
- 批准号:22007039
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
- 批准号:
- 批准年份:2019
- 资助金额:10.0 万元
- 项目类别:省市级项目
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
- 批准号:21372217
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
- 批准号:21172061
- 批准年份:2011
- 资助金额:30.0 万元
- 项目类别:面上项目
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
- 批准号:21176225
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
- 批准号:81072511
- 批准年份:2010
- 资助金额:31.0 万元
- 项目类别:面上项目
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
- 批准号:30660215
- 批准年份:2006
- 资助金额:21.0 万元
- 项目类别:地区科学基金项目
相似海外基金
CAREER: Highly Rapid and Sensitive Nanomechanoelectrical Detection of Nucleic Acids
职业:高度快速、灵敏的核酸纳米机电检测
- 批准号:
2338857 - 财政年份:2024
- 资助金额:
$ 52.61万 - 项目类别:
Continuing Grant
Lipid nanoparticle-mediated Inhalation delivery of anti-viral nucleic acids
脂质纳米颗粒介导的抗病毒核酸的吸入递送
- 批准号:
502577 - 财政年份:2024
- 资助金额:
$ 52.61万 - 项目类别:
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 52.61万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 52.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
- 批准号:
2300890 - 财政年份:2023
- 资助金额:
$ 52.61万 - 项目类别:
Continuing Grant
Integrated understanding and manipulation of hypoxic cellular functions by artificial nucleic acids with hypoxia-accumulating properties
具有缺氧累积特性的人工核酸对缺氧细胞功能的综合理解和操纵
- 批准号:
23H02086 - 财政年份:2023
- 资助金额:
$ 52.61万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 52.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 52.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 52.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Synthetic analogues based on metabolites of omega-3 fatty acids protect mitochondria in aging hearts
基于 omega-3 脂肪酸代谢物的合成类似物可保护衰老心脏中的线粒体
- 批准号:
477891 - 财政年份:2023
- 资助金额:
$ 52.61万 - 项目类别:
Operating Grants